Optimax faces a moderately high competition from other private eye specialists as well as from the public healthcare providers. Fees charged by the government sector are significantly lower compared to the private sector. In the private sector, Optimax competes mainly with ISEC Healthcare LTD, Top Vision Eye Specialist Bhd and Vista Eye Specialist. The industry competes based on pricing of consultation as well as surgical procedures, reputation and location. As such, there is a risk of losing market share to competitors especially when the peers keep expanding their network.
I strongly agree with ronnie2u. Optimax faces tough competition from Top Vision who provide cheaper prices for cataract surgery and is expanding rapidly in Malaysia. In addition, Optimax is planning to build an eye hospital in Seremban but the place is already well served by Top Vision and Laser Pro clinics and it would have a tough time competing for patients. Whereas Top Vision is building a new hospital in Kuala Lumpur with many sub-specialities. Personally I would buy shares in Top Vision.
Please refer to the independent industry assessment report page 183 of the prospectus; Optimax has garnered gross profit of RM62.6 (YE2019) whilst Topvision RM18.6 (YE2018). No latest figures though
Important Optimax is at second place and Top Vision is on top. This is contrasting Optimax has cery good potential to replace Top Vision soon. So, is a very good potential share !
Some branches of optimax are co-owners with ophthalmologists and eye surgeons. Obviously these are the owners themselves. Will be very much hardworking
amarjeet8287, u need to subscribe via your e-banking (eg. Maybank2U). subscribe doesn't mean you will definitely get the number of shares you want, have to wait for balloting. But you are slightly too late for this IPO as the subscription closing date was on 4 Aug 5pm.
A total of 16,258 applications for 1,121,418,500 IPO Shares were received from the Malaysian public for 13,500,000 IPO Shares made available for public subscription, representing an overall oversubscription rate of 82.07 times.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
nicS1128
35 posts
Posted by nicS1128 > 2020-07-25 13:18 | Report Abuse
Any1 subscribed IPO?